The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Sepsis Diagnostics-Global Market Insights and Sales Trends 2024

Sepsis Diagnostics-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1845846

No of Pages : 114

Ask Your Query

Synopsis

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.

Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.

The global Sepsis Diagnostics market size is expected to reach US$ 528.8 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Sepsis Diagnostics in various end use industries. The expanding demands from the Hospitals and Pathology & Reference Laboratories, are propelling Sepsis Diagnostics market. Microbiology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.

North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sepsis Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Sepsis Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Sepsis Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sepsis Diagnostics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Sepsis Diagnostics covered in this report include Biomerieux, T2 Biosystems, Luminex, Becton, Dickinson, Roche, Danaher, Thermo Fisher, Bruker and Abbott, etc.

The global Sepsis Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Biomerieux
  • T2 Biosystems
  • Luminex
  • Becton, Dickinson
  • Roche
  • Danaher
  • Thermo Fisher
  • Bruker
  • Abbott
  • Immunexpress
  • Response Biomedical
  • Axis-Shield Diagnostics
  • Cytosorbents
  • Mitsubishi Chemical
  • EKF Diagnostics

Global Sepsis Diagnostics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Sepsis Diagnostics market, Segment by Type:

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

Global Sepsis Diagnostics market, by Application

  • Hospitals
  • Pathology & Reference Laboratories

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sepsis Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Sepsis Diagnostics
1.1 Sepsis Diagnostics Market Overview
1.1.1 Sepsis Diagnostics Product Scope
1.1.2 Sepsis Diagnostics Market Status and Outlook
1.2 Global Sepsis Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sepsis Diagnostics Market Size by Region (2018-2029)
1.4 Global Sepsis Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Sepsis Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sepsis Diagnostics Market Size (2018-2029)
1.6.1 North America Sepsis Diagnostics Market Size (2018-2029)
1.6.2 Europe Sepsis Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Sepsis Diagnostics Market Size (2018-2029)
1.6.4 Latin America Sepsis Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Sepsis Diagnostics Market Size (2018-2029)
2 Sepsis Diagnostics Market by Type
2.1 Introduction
2.1.1 Microbiology
2.1.2 Molecular Diagnostics
2.1.3 Immunoassays
2.1.4 Flow Cytometry
2.1.5 Microfluidics
2.1.6 Biomarkers
2.2 Global Sepsis Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sepsis Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Sepsis Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sepsis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sepsis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sepsis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sepsis Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sepsis Diagnostics Revenue Breakdown by Type (2018-2029)
3 Sepsis Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Pathology & Reference Laboratories
3.2 Global Sepsis Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sepsis Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Sepsis Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sepsis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sepsis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sepsis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sepsis Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sepsis Diagnostics Revenue Breakdown by Application (2018-2029)
4 Sepsis Diagnostics Competition Analysis by Players
4.1 Global Sepsis Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sepsis Diagnostics as of 2022)
4.3 Date of Key Players Enter into Sepsis Diagnostics Market
4.4 Global Top Players Sepsis Diagnostics Headquarters and Area Served
4.5 Key Players Sepsis Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Sepsis Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biomerieux
5.1.1 Biomerieux Profile
5.1.2 Biomerieux Main Business
5.1.3 Biomerieux Sepsis Diagnostics Products, Services and Solutions
5.1.4 Biomerieux Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Biomerieux Recent Developments
5.2 T2 Biosystems
5.2.1 T2 Biosystems Profile
5.2.2 T2 Biosystems Main Business
5.2.3 T2 Biosystems Sepsis Diagnostics Products, Services and Solutions
5.2.4 T2 Biosystems Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 T2 Biosystems Recent Developments
5.3 Luminex
5.3.1 Luminex Profile
5.3.2 Luminex Main Business
5.3.3 Luminex Sepsis Diagnostics Products, Services and Solutions
5.3.4 Luminex Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Becton, Dickinson Recent Developments
5.4 Becton, Dickinson
5.4.1 Becton, Dickinson Profile
5.4.2 Becton, Dickinson Main Business
5.4.3 Becton, Dickinson Sepsis Diagnostics Products, Services and Solutions
5.4.4 Becton, Dickinson Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Becton, Dickinson Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Sepsis Diagnostics Products, Services and Solutions
5.5.4 Roche Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Danaher
5.6.1 Danaher Profile
5.6.2 Danaher Main Business
5.6.3 Danaher Sepsis Diagnostics Products, Services and Solutions
5.6.4 Danaher Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Danaher Recent Developments
5.7 Thermo Fisher
5.7.1 Thermo Fisher Profile
5.7.2 Thermo Fisher Main Business
5.7.3 Thermo Fisher Sepsis Diagnostics Products, Services and Solutions
5.7.4 Thermo Fisher Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Recent Developments
5.8 Bruker
5.8.1 Bruker Profile
5.8.2 Bruker Main Business
5.8.3 Bruker Sepsis Diagnostics Products, Services and Solutions
5.8.4 Bruker Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Bruker Recent Developments
5.9 Abbott
5.9.1 Abbott Profile
5.9.2 Abbott Main Business
5.9.3 Abbott Sepsis Diagnostics Products, Services and Solutions
5.9.4 Abbott Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Abbott Recent Developments
5.10 Immunexpress
5.10.1 Immunexpress Profile
5.10.2 Immunexpress Main Business
5.10.3 Immunexpress Sepsis Diagnostics Products, Services and Solutions
5.10.4 Immunexpress Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Immunexpress Recent Developments
5.11 Response Biomedical
5.11.1 Response Biomedical Profile
5.11.2 Response Biomedical Main Business
5.11.3 Response Biomedical Sepsis Diagnostics Products, Services and Solutions
5.11.4 Response Biomedical Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Response Biomedical Recent Developments
5.12 Axis-Shield Diagnostics
5.12.1 Axis-Shield Diagnostics Profile
5.12.2 Axis-Shield Diagnostics Main Business
5.12.3 Axis-Shield Diagnostics Sepsis Diagnostics Products, Services and Solutions
5.12.4 Axis-Shield Diagnostics Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Axis-Shield Diagnostics Recent Developments
5.13 Cytosorbents
5.13.1 Cytosorbents Profile
5.13.2 Cytosorbents Main Business
5.13.3 Cytosorbents Sepsis Diagnostics Products, Services and Solutions
5.13.4 Cytosorbents Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Cytosorbents Recent Developments
5.14 Mitsubishi Chemical
5.14.1 Mitsubishi Chemical Profile
5.14.2 Mitsubishi Chemical Main Business
5.14.3 Mitsubishi Chemical Sepsis Diagnostics Products, Services and Solutions
5.14.4 Mitsubishi Chemical Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Mitsubishi Chemical Recent Developments
5.15 EKF Diagnostics
5.15.1 EKF Diagnostics Profile
5.15.2 EKF Diagnostics Main Business
5.15.3 EKF Diagnostics Sepsis Diagnostics Products, Services and Solutions
5.15.4 EKF Diagnostics Sepsis Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 EKF Diagnostics Recent Developments
6 North America
6.1 North America Sepsis Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sepsis Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sepsis Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sepsis Diagnostics Market Dynamics
11.1 Sepsis Diagnostics Industry Trends
11.2 Sepsis Diagnostics Market Drivers
11.3 Sepsis Diagnostics Market Challenges
11.4 Sepsis Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock